Impact BioMedical, Inc.

IBOAMEX • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.57 USD
↗ 0.00 (0.44%)AT CLOSE (11:59 AM EDT)
0.58
↗ 0.01 (2.24%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
0.58
↗ 0.01 (2.24%)
🔴Market: CLOSED
Open?$0.55
High?$0.57
Low?$0.55
Prev. Close?$0.56
Volume?76.7K
Avg. Volume?51.5K
VWAP?$0.56
Rel. Volume?1.49x
Bid / Ask
Bid?$0.55 × 100
Ask?$0.58 × 500
Spread?$0.03
Midpoint?$0.57
Valuation & Ratios
Market Cap?61.5M
Shares Out?107.8M
Float?1.3M
Float %?10.9%
P/E Ratio?N/A
P/B Ratio?5.36
EPS?-$0.12
Dividend?0.00%
Ex-Dividend?N/A

Impact BioMedical, Inc. (IBO) trades at $0.57 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
8
Market Cap
61.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.impactbiomedinc.com
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
20
Piotroski F-Score?0/9Weak
Altman Z-Score?10.12Safe
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?59.18%Squeeze Risk
Short Interest?783.9K
Days to Cover?13.7
Free Float1.3M
Avg Daily Volume57.4K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.22Weak
Quick Ratio?0.19Weak
Cash Ratio?0.01Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
35
5.36FAIR▾
P/S?
Peers
100
S&P
3
1,575.85HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-14.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,575.34HIGH▾
Returns & Efficiency
ROE?
S&P
3
-112.2%WEAK▾
ROA?
S&P
3
-75.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$61.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist